Hc. Champion et al., RESPONSES TO ANGIOTENSIN PEPTIDES ARE MEDIATED BY AT(1) RECEPTORS IN THE RAT, American journal of physiology: endocrinology and metabolism, 37(1), 1998, pp. 115-123
The effects of the angiotensin AT(1) and AT(2) receptor antagonists ca
ndesartan and PD-123,319 on hemodynamic responses to angiotensin pepti
des were investigated in the anesthetized rat. Injections of angiotens
in II and III caused dose-related increases in systemic arterial and i
n hindquarters perfusion pressure that were reduced in an insurmountab
le manner by candesartan. Presser responses to angiotensin IV were als
o attenuated, and a vasodepressor or vasodilator response to the angio
tensin peptides was not unmasked by the AT(1) receptor antagonists can
desartan or losartan. The AT(2) receptor antagonist PD123,319 had no s
ignificant effect on increases in systemic arterial and hindquarters p
erfusion pressure in response to the angiotensin peptides. Presser res
ponses to angiotensin peptides were not altered by adrenergic nerve te
rminal and alpha-receptor blocking agents or by the cyclooxygenase inh
ibitor sodium meclofenamate but were increased by an inhibitor of nitr
ic oxide synthase. The present results suggest that presser responses
to the angiotensin peptides are mediated by the activation of AT(1) re
ceptors and that AT(2) receptors, the adrenergic system, or cyclooxyge
nase products do not appear to modulate hemodynamic responses to the a
ngiotensin peptides in the anesthetized rat.